Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...

Medtronic said it has won an FDA nod for an implantable tibial neuromodulation therapy that treats urge urinary incontinence. The Altaviva device is inserted near the ankle. The Dublin-based company ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...

Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...

Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ankle designed to be more convenient and accessible. Compared to other ...

Add Yahoo as a preferred source to see more of our stories on Google. The partnership aims to broaden the range of support services available to individuals experiencing bladder control issues. Credit ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...